Skip to main content

Advertisement

Log in

Increased uptake of 131I-MIBG after intra-arterial application in liver metastases of a neuroendocrine tumor

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hendlisz A, Flamen P, Van den Eynde M, et al. Locoregional and radioisotopic targeted treatment of neuroendocrine tumours. Acta Gastroenterol Belg. 2009;72:44–8.

    CAS  PubMed  Google Scholar 

  2. Khan MU, Morse M, Coleman RE. Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors. Q J Nucl Med Mol Imaging. 2008;52:441–54.

    CAS  PubMed  Google Scholar 

  3. Brogsitter C, Pinkert J, Bredow J, Kittner T, Kotzerke J. Enhanced tumor uptake in neuroendocrine tumors after intraarterial application of 131I-MIBG. J Nucl Med. 2005;46:2112–6.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jörg Kotzerke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Popp, M., Strumpf, A., Zöphel, K. et al. Increased uptake of 131I-MIBG after intra-arterial application in liver metastases of a neuroendocrine tumor. Eur J Nucl Med Mol Imaging 37, 180 (2010). https://doi.org/10.1007/s00259-009-1277-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-009-1277-8

Keywords

Navigation